(Q52872428)

9 May 2018

title

Peri-operative modulation of cellular immunity in patients with colorectal cancer. (English)

1 reference

9 May 2018

1 reference

Nichols PH

1

1 reference

9 May 2018

Ramsden CW

2

1 reference

9 May 2018

Ward U

3

1 reference

9 May 2018

Trejdosiewicz LK

4

1 reference

9 May 2018

Ambrose NS

5

1 reference

9 May 2018

Primrose JN

6

1 reference

9 May 2018

publication date

1 October 1993

1 reference

9 May 2018

Clinical and Experimental Immunology

published in

1 reference

9 May 2018

volume

94

1 reference

9 May 2018

issue

1

1 reference

9 May 2018

page(s)

4-10

1 reference

9 May 2018

Immunodepression after major surgery in normal patients

cites work

1 reference

12 December 2020

CIRCULATING CANCER CELLS DURING EXCISION OF CARINOMAS OF THE RECTUM AND COLON WITH HIGH LIGATION OF THE INFERIOR MESENTERIC VEIN

1 reference

12 December 2020

Cytotoxic reactivity of human lymphocytes cultured in vitro

1 reference

12 December 2020

Halothane, surgery, immunosuppression and artificial pulmonary metastases

1 reference

12 December 2020

T cell growth factor: parameters of production and a quantitative microassay for activity

1 reference

12 December 2020

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1 reference

12 December 2020

The influence of surgical operations on components of the human immune system

1 reference

12 December 2020

Prevention of growth of metastases in rat liver by perioperative immunoactivation

1 reference

12 December 2020

Decreased interleukin-2 production in patients with gastrointestinal cancer

1 reference

12 December 2020

Interferon therapy in cancer: from imaginon to interferon.

1 reference

12 December 2020

Do operations facilitate tumor growth? An experimental model in rats

1 reference

12 December 2020

Occult hepatic metastases in colorectal carcinoma

1 reference

12 December 2020

High-dose recombinant interleukin 2 in the treatment of patients with disseminated cancer. Responses, treatment-related morbidity, and histologic findings

1 reference

12 December 2020

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

12 December 2020

Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer

1 reference

12 December 2020

Outcome of colorectal cancer

1 reference

12 December 2020

Recombinant interleukin 2 toxicity, pharmacokinetics, and immunomodulatory effects in a phase I trial

1 reference

12 December 2020

Five year results of a randomized trial of adjuvant 5-fluorouracil and levamisole in colorectal cancer

1 reference

12 December 2020

Immunotherapy of a murine tumor with interleukin 2. Increased sensitivity after MHC class I gene transfection

1 reference

12 December 2020

In vivo antitumor activity of multiple injections of recombinant interleukin 2, alone and in combination with three different types of recombinant interferon, on various syngeneic murine tumors

1 reference

12 December 2020

Phase II trial of recombinant alpha-2b-interferon and low-dose cyclophosphamide in advanced melanoma and renal cell carcinoma.

1 reference

12 December 2020

In vivo effects of recombinant IL-2. I. Isolation of circulating Leu-19+ lymphokine-activated killer effector cells from cancer patients receiving recombinant IL-2.

1 reference

12 December 2020

Interleukin-2: inception, impact, and implications

1 reference

12 December 2020

Interferons as biologic modulators of hematopoietic cell proliferation and differentiation

1 reference

12 December 2020

Effects of low dose perioperative interferon on the surgically induced suppression of antitumour immune responses

1 reference

12 December 2020

Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma

1 reference

12 December 2020

In vivo activation of lymphokine-activated killer activity with interleukin-2: prospects for combination therapies

1 reference

12 December 2020

Lymphokines and cytokines as cancer treatment. Immunotherapy realized

1 reference

12 December 2020

Home therapy with recombinant interleukin-2 and interferon-alpha 2b in advanced human malignancies

1 reference

12 December 2020

Adhesion receptors of the immune system

1 reference

12 December 2020

Simplified quantitation of cytotoxicity by integration of specific lysis against effector cell concentration at a constant target cell concentration and measuring the area under the curve

1 reference

12 December 2020

Perioperative immunotherapy with recombinant interleukin 2 in patients undergoing surgery for colorectal cancer

1 reference

12 December 2020

Effects of operation on immune response in cancer patients: sequential evaluation of in vitro lymphocyte function

1 reference

12 December 2020

10.1111/J.1365-2249.1993.TB05968.X

Identifiers

DOI

1 reference

9 May 2018

1 reference

9 May 2018